EUVIMEDEUVIMED entdecken
Crossref

Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis

Olga Demska iD, Jean-Christophe Ianotto iD, Marta Szandruk-Bender iD, Danijela Leković iD, Weronika Lebowa iD, Tomasz Sacha iD, Aleksandra Gołos iD, Patryk Sobieralski iD, Marek Skarupski, Magdalena Karasek, Sebastian Szmit iD, Katie Erdos und 2 weitere

Thrombosis and Haemostasis · 13.05.2026

DOI: 10.1055/a-2869-7105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 13.05.2026. Verfasst von Olga Demska und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Bydgoszcz, Poland.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are clonal hematopoietic disorders characterized by an increased risk of thrombotic complications due to a persistent pro-thrombotic and inflammatory state. Atrial fibrillation (AF) is a common cardiac arrhythmia and an established risk factor for thromboembolism; however, its impact on thrombotic complications in patients with MPN remains incompletely characterized. Material and Methods This multicenter, real-world retrospective study analyzed 2,683 MPN patients diagnosed between 1976 and 2024 to investigate the impact of AF on thrombotic events, bleeding risk, and survival outcomes.

Results

Patients with MPN and AF (MPN-AF) had a higher rate of thrombotic events, with arterial thrombosis predominating (67% vs. 43%, p < 0.0001). Despite this arterial phenotype, 36.7% of MPN-AF patients did not receive antiplatelet therapy. Thrombosis rates remained high in AF patients despite cytoreductive therapy. Kaplan–Meier analysis revealed that AF was linked to significantly shorter overall survival (181 months vs. 265 months, HR: 1.86, 95% CI: 1.53–2.26, p < 0.0001), particularly in essential thrombocythemia and MF subtypes.

Conclusion

Our findings highlight that the thrombotic profile of MPN patients with AF differs from that observed in the general AF population, with a clear predominance of arterial events. Conventional AF management focused on anticoagulation may incompletely address the predominantly arterial thrombotic phenotype observed in MPN. The treatment patterns observed in our cohort–with frequent reliance on anticoagulation alone and limited use of antiplatelet therapy–suggest a need for more disease-adapted antithrombotic considerations in this subgroup. Prospective studies are needed to clarify the contribution of inflammatory and vascular mechanisms to thrombotic risk in MPN-AF.

Autor:innen und Institutionen

  • Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Bydgoszcz, Poland.
  • Service d'hématologie Clinique, Institut de Cancérologie et d'hématologie, CHU de Brest, Brest-France.
  • Department of Hematology and Clinical Hemostasis, Brest University Hospital, Brest, France.
  • Faculty of Medicine, Department of Pharmacology, Wroclaw Medical University, Wrocław, Lower Silesian Voivodeship, Poland.
  • Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

ORCID-Profile: Olga Demska, Jean-Christophe Ianotto, Marta Szandruk-Bender, Danijela Leković, Weronika Lebowa, Tomasz Sacha, Aleksandra Gołos, Patryk Sobieralski, Sebastian Szmit, Joseph Michael Scandura, Marta Sobas

Zitieren

APA

Demska, O., Ianotto, J. C., Szandruk-Bender, M., Leković, D., Lebowa, W., Sacha, T., Gołos, A., Sobieralski, P., Skarupski, M., Karasek, M., Szmit, S., Erdos, K., Scandura, J. M., & Sobas, M. (2026). Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2869-7105

Vancouver

Demska O, Ianotto JC, Szandruk-Bender M, Leković D, Lebowa W, Sacha T, et al. Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2869-7105

BibTeX
@article{Demska2026,
  author = {Demska, Olga and Ianotto, Jean-Christophe and Szandruk-Bender, Marta and Leković, Danijela and Lebowa, Weronika and Sacha, Tomasz and Gołos, Aleksandra and Sobieralski, Patryk and Skarupski, Marek and Karasek, Magdalena and Szmit, Sebastian and Erdos, Katie and Scandura, Joseph Michael and Sobas, Marta},
  title = {Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1055/a-2869-7105}
}
Kostenlos starten →